NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Take-Two Interactive Software, Inc. ("Take-Two" or "the Company") (NASDAQ:TTWO). Investors who purchased Take-Two securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TTWO.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coinbase Global, Inc. ("Coinbase" or "the Company") (NASDAQ:COIN). Investors who purchased Coinbase securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/COIN.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. ("Travere" or "the Company") (NASDAQ:TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TVTX.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schrödinger, Inc. ("Schrödinger" or "the Company") (NASDAQ:SDGR). Investors who purchased Schrödinger securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SDGR.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDAQ:GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GOCO.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ:CAPR). Investors who purchased Capricor securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAPR.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. ("Apple" or "the Company") (NASDAQ:AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AAPL.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Senti Biosciences, Inc. ("Senti" or "the Company") (NASDAQ:SNTI). Investors who purchased Senti securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SNTI.

Von Duprin's first offering engineered to protect internal components on outdoor applications CARMEL, Ind. , May 28, 2025 /PRNewswire/ -- Allegion US , a leading provider of security solutions, technology and services, has introduced the Outdoor Defense (OUT) option for 98/99 exit devices, the first Von Duprin product designed to protect device functionality in outdoor conditions, providing the reliability, quality and function expected from Von Duprin.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLGT.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADTRAN Holdings, Inc. ("ADTRAN" or "the Company") (NASDAQ:ADTN). Investors who purchased ADTRAN securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ADTN.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luminar Technologies, Inc. ("Luminar" or "the Company") (NASDAQ:LAZR). Investors who purchased Luminar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LAZR.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=150550&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

HOUSTON, TX, May 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on June 3, 2025, at 4:15 p.m. ET. Attendees will gain an inside look at Nexalin's game-changing approach to mental healthcare through its proprietary, non-invasive Deep Intracranial Frequency Stimulation (DIFS™) technology.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flowco Holdings Inc. ("Flowco" or "the Company") (NYSE:FLOC). Investors who purchased Flowco securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLOC.

MINNEAPOLIS--(BUSINESS WIRE)--Ameriprise Financial today announced the national launch of the Ameriprise® Signature Wealth Program, a flexible unified managed account.

MELVILLE, N.Y.--(BUSINESS WIRE)-- #AI--Verint® (NASDAQ: VRNT), The CX Automation Company™, today announced it signed a $13 million multi-year deal agreement with one of the top U.S. insurance companies. The deal includes several AI-powered bots to increase workforce capacity across its customer experience (CX) operations of 6,500 agents, with plans to scale deployment to more than 12,000 agents across the enterprise. The new workforce capacity will be achieved using Verint bots to automate repetitive.

COVINA, Calif.--(BUSINESS WIRE)--xtype, the Multi-Instance Governance Platform company, today released its inaugural 2025 State of ServiceNow Operations Report, revealing valuable insights into how organizations are governing their ServiceNow implementations. The comprehensive study examines operational practices across instance management, development processes, security, and governance - as well as Gen AI adoption - as organizations expand their ServiceNow footprints. Key Findings The 2025 St.

AUSTIN, Texas--(BUSINESS WIRE)--Today, Good Grief was announced as the winner of the 2025 Austin FC Dream Starter Competition presented by Q2 Holdings, Inc. (NYSE: QTWO). Good Grief will receive $100,000 in funding to accelerate its business and mission as part of the Austin FC Dream Starter business initiative, which supports Austin entrepreneurs. Good Grief makes a profoundly difficult time more manageable by supporting individuals and families facing the challenges of caregiving or loss of a.